Allan M. Fox, Director at REGENXBIO Inc. (RGNX), sold 96,466 shares at $45.04 ($4.3M) on 2021-09-17, disclosed to the SEC on 2021-09-21.
Open-market sale of $4.3M RGNX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.04 | 48,233 | $2.2M | 50.0% |
| 2 | $45.04 | 48,233 | $2.2M | 50.0% |
| Total | $45.04 avg | 96,466 | $4.3M | 100% |